Glimepiride Reduces the Expression of PrP C , Prevents PrP Sc Formation and Protects against Prion Mediated Neurotoxicity
Clive Bate, Mourad Tayebi, Luisa Diomede et al. · 2009
Read Glimepiride Reduces the Expression of PrP C , Prevents PrP Sc Formation and Protects against Prion Mediated Neurotoxicity by Clive Bate, Mourad Tayebi, Luisa Diomede et al. (2009) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0008221.txt.
Description
Clive Bate and colleagues tested a diabetes drug against prion disease in a PLOS ONE paper from 2009. Prion diseases turn a normal host protein into a misfolded, harmful form. That harmful form builds up in the brain. Its spread is tied to synapse loss and nerve cell death. Few treatments exist for these fatal diseases.
The drug glimepiride lowered expression of the normal prion protein in their tests. It also prevented formation of the disease form. Cells were protected against prion-mediated toxicity as a result. The findings suggest a common drug class might be worth exploring further.
Catalog record
| CREATOR | Clive Bate, Mourad Tayebi, Luisa Diomede et al. |
|---|---|
| YEAR | 2009 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 55 KB |
| LICENSE | Creative Commons Attribution License |
| RIGHTS | CC BY |
| SOURCE | PLOS ONE |
Source: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0008221